FDA hits Zhejiang Tianyu Pharmaceutical with a warning letter after the Chinese drugmaker failed to address  prior manufacturing problems.

 

09/27/2022	09/27/2022	Ecig Vapor Juice Store	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
09/27/2022	09/09/2022	System Kosmetik Produktionsgesellschaft fur kosmetische Gmbh	Center for Drug Evaluation and Research | CDER	CGMP/Finished Pharmaceuticals/Adulterated
09/27/2022	09/20/2022	Mena Produce LLC	Division of Southwest Imports	Foreign Supplier Verification Program (FSVP)
09/27/2022	09/02/2022	El Salvador Products Inc	Division of Southwest Imports	Foreign Supplier Verification Program (FSVP)
09/27/2022	09/15/2022	Med Pen Concepts, LLC	Center for Devices and Radiological Health	CGMP/QSR/Medical Devices/Adulterated/Misbranded
09/27/2022	09/22/2022	Vapeoholic LLC	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
09/27/2022	09/22/2022	GN Tobacco Sweden AB d/b/a White Fox USA	Center for Tobacco Products	Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
09/27/2022	09/23/2022	Muscle Sports Products, LLC	Office of Human and Animal Food Operations East – Division 1	Unapproved New Drugs/Misbranded
09/27/2022	08/17/2022	Zhejiang Tianyu Pharmaceutical Co., Ltd.	Center for Drug Evaluation and Research | CDER	CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

New book recounts the FDA’s ‘unholy birth’ By Erin Blakemore September 26, 2022 at 7:12 a.m. EDT

 "Sekeres writes about everything from the FDA’s painstaking 1937 search for remaining bottles of a deadly elixir with antifreeze in it to the agency’s 1962 demand that drugs be both safe and effective to be marketed in the United States."

https://www.washingtonpost.com/wellness/2022/09/26/fda-drug-safety-history/

 

09/13/2022

08/29/2022

Texas Longhorn RX, LLC

Office of Pharmaceutical Quality Operations, Division II

Compounding Pharmacy/Adulterated Drug Products

Walgreens to acquire remaining stake in Shields Health for $1.37B, announces exec moves By Annie Burky

 

Walgreens to acquire remaining stake in Shields Health for $1.37B, announces exec moves

 

Statement on state laws impacting patient access to necessary ...

https://www.ama-assn.org › press-center › press-releases

2 days ago — Physicians and pharmacists need clear guidance from state boards of medicine and pharmacy, agencies, and policymakers to support the prescribing and dispensing ..

 

Public Hearing on Proposed Rule Changes

https://www.pharmacyboard.arkansas.gov › event › pu...

3 days ago — On Wednesday, October 19, 2022, at 1:00 PM, the Arkansas State Board of Pharmacy will hold a public hearing in the Arkansas State Board of Pharmacy Offices, 

 Alabama AG overrides state pharmacy board on revoked license - al.com

AG’s office tosses charges against pharmacist, opens investigation into Pharmacy Board

https://www.alreporter.com/2022/09/08/ags-office-tosses-charges-against-pharmacist-opens-investigation-into-pharmacy-board/#:~:text=Sweet%20Home%20Alabama%3F-,STATE,announced%20an%20investigation%20into%20the%20Pharmacy%20Board%E2%80%99s%20actions%20in%20the%20case.,-By 

 

USP 797, USP 800: An Upgrade Checklist for Hospital ...

https://www.haskell.com › News & Insights

4 days ago — USP 800, which became effective in late 2019, sets out expectations for the safe handling of hazardous drugs in pharmacies, involving not only tight ..